AltheRx.com

AltheRx Pharmaceuticals

AltheRx HOMEABOUT AltheRxAltheRx DEVELOPMENT PROGRAMNEWSROOMCAREERS AT AltheRxCONTACT AltheRx

   
 
 
   
 

AltheRx™ Pharmaceuticals is a privately held, clinical development company focused on advancing best-in-class compounds with high promise in large unmet markets. Its lead product, solabegron, is a highly differentiated novel compound being investigated for overactive bladder (OAB) and irritable bowel syndrome (IBS). AltheRx is focused on creating strategic partnerships that complement its development and commercialization capabilities globally for this promising medicine.  Learn more >

 

OCTOBER 17, 2013
AltheRx Pharmaceuticals is Granted U.S. Patent for Use of Solabegron in Combination with Antimuscarinics for the Treatment of Overactive Bladder

MAY 30, 2013
AltheRx Pharmaceuticals Appoints Michael R Dougherty to Board of Directors